home / stock / rnxt / rnxt quote
Last: | $1.18 |
---|---|
Change Percent: | -0.86% |
Open: | $1.17 |
Close: | $1.18 |
High: | $1.18 |
Low: | $1.14 |
Volume: | 33,417 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.18 | $1.17 | $1.18 | $1.18 | $1.14 | 33,417 | 07-22-2024 |
$1.16 | $1.22 | $1.16 | $1.22 | $1.1 | 43,478 | 07-19-2024 |
$1.19 | $1.3 | $1.19 | $1.31 | $1.15 | 49,231 | 07-18-2024 |
$1.27 | $1.27 | $1.27 | $1.3 | $1.26 | 5,741 | 07-17-2024 |
$1.25 | $1.28 | $1.25 | $1.28 | $1.22 | 13,175 | 07-16-2024 |
$1.28 | $1.3 | $1.28 | $1.31 | $1.262 | 18,519 | 07-15-2024 |
$1.2913 | $1.15 | $1.2913 | $1.2913 | $1.15 | 97,439 | 07-12-2024 |
$1.17 | $1.14 | $1.17 | $1.1974 | $1.14 | 7,670 | 07-11-2024 |
$1.16 | $1.24 | $1.16 | $1.24 | $1.15 | 40,942 | 07-10-2024 |
$1.18 | $1.17 | $1.18 | $1.1934 | $1.15 | 9,845 | 07-09-2024 |
$1.21 | $1.14 | $1.21 | $1.215 | $1.14 | 39,611 | 07-08-2024 |
$1.135 | $1.11 | $1.135 | $1.1911 | $1.11 | 20,131 | 07-05-2024 |
$1.12 | $1.11 | $1.12 | $1.149 | $1.11 | 7,360 | 07-04-2024 |
$1.12 | $1.11 | $1.12 | $1.149 | $1.11 | 7,360 | 07-03-2024 |
$1.13 | $1.11 | $1.13 | $1.15 | $1.11 | 20,913 | 07-02-2024 |
$1.15 | $1.15 | $1.15 | $1.16 | $1.112 | 15,320 | 07-01-2024 |
$1.13 | $1.23 | $1.13 | $1.23 | $1.13 | 28,690 | 06-28-2024 |
$1.16 | $1.2 | $1.16 | $1.2 | $1.11 | 17,535 | 06-27-2024 |
$1.13 | $1.11 | $1.13 | $1.18 | $1.11 | 27,621 | 06-26-2024 |
$1.13 | $1.09 | $1.13 | $1.2139 | $1.0801 | 61,541 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
LOS ALTOS, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today annou...
LOS ALTOS, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced t...
LOS ALTOS, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, announced t...